GlaxoSmithKline Pakistan Limited (PSX: GLAXO)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
174.25
+10.87 (6.65%)
At close: Sep 9, 2024

GlaxoSmithKline Pakistan Ratios and Metrics

Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
56,07626,43027,95243,47461,09251,136
Upgrade
Market Cap Growth
90.85%-5.45%-35.70%-28.84%19.47%42.50%
Upgrade
Enterprise Value
53,15622,63120,59138,01357,10250,853
Upgrade
Last Close Price
176.0882.9987.77129.72174.89141.47
Upgrade
PE Ratio
22.3449.5011.357.7216.5014.81
Upgrade
PS Ratio
1.010.530.671.191.741.40
Upgrade
PB Ratio
2.521.221.332.073.503.17
Upgrade
P/FCF Ratio
--487.34-5.9511.8013.1541.83
Upgrade
P/OCF Ratio
-16.57-8.848.7210.2519.93
Upgrade
EV/Sales Ratio
0.960.460.491.041.631.39
Upgrade
EV/EBITDA Ratio
9.977.853.484.9810.099.07
Upgrade
EV/EBIT Ratio
12.4211.524.065.5311.6310.57
Upgrade
EV/FCF Ratio
--417.30-4.3910.3212.3041.60
Upgrade
Debt / Equity Ratio
0.010.030.020.010.020.00
Upgrade
Debt / EBITDA Ratio
0.030.250.060.040.070.01
Upgrade
Debt / FCF Ratio
--13.37-0.070.080.080.04
Upgrade
Asset Turnover
-1.351.271.301.421.61
Upgrade
Inventory Turnover
-4.304.204.244.484.62
Upgrade
Quick Ratio
-0.830.921.401.130.80
Upgrade
Current Ratio
-1.741.822.282.042.04
Upgrade
Return on Equity (ROE)
-2.50%11.72%27.84%20.08%19.27%
Upgrade
Return on Assets (ROA)
-3.33%9.60%15.20%12.45%13.24%
Upgrade
Return on Capital (ROIC)
12.40%5.61%14.85%21.96%18.03%19.02%
Upgrade
Earnings Yield
4.48%2.02%8.81%12.32%5.52%5.95%
Upgrade
FCF Yield
-0.21%-16.79%8.47%7.60%2.39%
Upgrade
Dividend Yield
0.00%--5.40%3.72%4.24%
Upgrade
Payout Ratio
0.00%345.56%15.23%38.51%56.04%72.99%
Upgrade
Total Shareholder Return
-0.01%--5.40%3.72%4.24%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.